Pharma Journalist - Page 827 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Agenda released for SMi Group’s Adaptive Designs in Clinical Trials 2018

Superbugs: Exclusive Interviews Released with ABAC Therapeutics, Alchemy Biomedical and Oppilotech

Zubsolv receives authorization for Treatment of Opioid Dependence in Europe

Novartis, ASCP and ACS join forces to fight cancer in Ethiopia, Uganda and Tanzania

Ionis Pharmaceuticals Licenses Second Orally Delivered Antisense Drug to Janssen

Cerecor acquires TRx Pharmaceuticals

Samsung Bioepis receives regulatory approval for Trastuzumab Biosimilar, ONTRUZANT

AVEO Oncology appoints Nikil Mehta as SVP of Regulatory and Quality Assurance

Revance announces Orphan Drug Designation of RT002 for the Treatment of Cervical Dystonia

Faslodex receives FDA approval for the treatment of advanced breast cancer in combination with abemaciclib